Podophyllum hexandrum Royle, a rhizomatous perennial herb from the Berberidaceae family, is a highly reputed medicinal plant known for its lignan, podophyllotoxin. Podophyllotoxin and its semisynthetic derivativatives are potent anticancer agents. The semisynthetic analogues of podophyllotoxin are also used in the treatment of lung cancer, testicular cancer, neuroblastoma, hepatoma and other tumor diseases. While Podophyllotoxin acts as an inhibitor of the microtubule assembly, the cytotoxic action of its derevatives is based on the inhibition of topoisomerase. Owing to the ever-increasing demand of Podophyllum hexandrum for podophyllotoxin, it has been subjected to heavy collection from the wild. The anti-cancer lignan derivative podophyllotoxin is biosynthesized at very low quantities in intact Podophyllum hexandrum plant and the whole plant is harvested to isolate the bioactive lignan adding to the threats that the plant is currently facing. Therefore, biotechnological production of podophyllotoxin has been considered essential. The present review gives a brief introduction about the phytochemistry, pharmacology and biosynthesis of podophyllotoxin and also discusses the potential of biotechnology for production of podophyllotoxin to meet the increasing demand of this highly valued plant metabolite.
Introduction
Podophyllum hexandrum is a rhizomatous perennial herb distributed in Himalayas at an altitude of about 3000-4000msl. It belongs to family Berberidaceae and is commonly known as Himalayan May apple. The genus Podophyllum is represented by five species including P. hexandrum, P. peltatum, and P. sikkimensis. Of these Podophyllum species, P. hexandrum is medicinally more valuable, containing comparatively higher concentration of podophyllotoxin. Podophyllum peltatum contains 4-5% podophyllum resin, whereas P. hexandrum contains 7-16 % [1] [2] [3] . P. hexandrum is a cold tolerant plant propagating either by seed or by dividing the perennial rhizome [4] . The part above ground is annual, emerging about the middle of April with a reddish and succulent stem. The stem bears a pair of leaves and the stem becomes 15-30 cm tall before the leaves are fully developed (Fig.1) . The leaves are about 25 cm wide and are often spotted. A bud arises from the stalk of one of the leaves and bears a white flower in the month of May. The fruit grows to the size of a lemon, ripens in August or September, with a bright orange color. The roots and rhizomes of P. hexandrum are rich sources of podophyllotoxin which has cytotoxic and antitumor properties. Podophyllotoxin is used for the preparation of semisynthetic derivatives that are clinically applied as cytostatics in the treatment of several types of cancer, dermatological disorders, rheumatoid arthritis and psoriasis [5] . Recently P. hexandrum extracts have been found to offer radioprotection by modulating free radical
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flux involving the role of lignans present [6] hexandrum has been subjected to heavy collection from the wild due to its ever increasing demand and reckless harvesting in wild. Since the artificial synthesis of podophyllotoxin is not economically feasible, the whole plant is harvested to extract the podophyllotoxin and its derevatives, leading to the overexploitation of the plant in wild. To ensure the continued supply of podophyllotoxin without effecting the natural populations of the plant, large scale cultivation of Podophyllum hexandrum by micro propagation, or alternatively the production of podophyllotoxin from plant tissue cultures is the need of the hour. Recent advances in the identification of the genes and enzymes responsible for the biosynthesis of podophyllotoxin have made metabolic engineering highly feasible which offers also enormous potential for enhancing the production of podophyllotoxin. This besides assuring the continuous supply of podophyllotoxin will also control the reckless harvesting of the plant in wild.
Biosynthetic pathway of podophyllotoxin
Podophyllum hexandrum is the source of podophyllotoxin used for semi-synthesis of various powerful and extensively employed cancer-treating drugs. Podophyllotoxin biosynthetic pathway has not been fully elucidated so far, however a putative pathway for podophyllotoxin biosynthesis has been proposed. The early steps of pathway until matairesinol were elucidated using Forsythia intermedia as model system [7] and recently some other important steps in podophyllotoxin biosynthetic pathway have been studied which includes the cloning and characterization of Secoisolariciresinol dehydrogenase, from a Podophyllum peltatum rhizome cDNA library [8] .The enzyme Secoisolariciresinol dehydrogenase has been shown to catalyze the enantiospecific conversion of secoisolariciresinol into matairesinol via the intermediary lactol [9] . Transcriptome sequencing of Podophyllum hexandrum and Podophyllum peltatum was carried recently and is likely to through light the various aspects of podophyllotoxin biosynthesis [8] . The characterization of cytochrome P450s, CYP719A23 from P. hexandrum and CYP719A24 from P. peltatum is another important breakthrough in understanding lignan biosynthesis in Podophyllum hexandrum [8] .This pioneering work will serve as a keystone in the podophyllotoxin pathway development.
Chemistry
Plants show a tremendous diversity in the production of secondary metabolites to defend themselves against attack by pathogens, and lignans play an important role in this type of plant defense. The rhizomes and roots of Podophyllum hexandrum contain medicinally important lignans. The important active constituents of the plant include Podophyllotoxin, picropodophyllotoxin, 4-demethyl podophyllotoxin glucoside, deoxypodophyllotoxin, isopicropodophyllone (Fig. 2) .
Podophyllotoxin is a well-known naturally occurring bioactive aryltetralin lignan. It was first isolated by Podwyssotzki in 1880 from the North American plant Podophyllum peltatum and later on, it was also isolated from P. hexandrum which was found to contain comparatively higher concentration of podophyllotoxin than Podophyllum peltatum. Etoposide and teniposide and other semisynthetic derivatives of podophyllotoxin are currently used in cancer chemotherapy against various cancers [9] .
Podophyllotoxin derivatives
In order to overcome the side effects of podophyllotoxin as a drug, extensive structural modifications have been performed on podophyllotoxin to obtain analogues with better activity and/or less toxicity. These modifications have led to the development of many semisynthetic derivatives of podophyllotoxin which include etoposide, teniposide, etoposide phosphate and NK611, GL331, TOP-53 and Tafluposide [10, 11] (Fig.3) Etoposide is used in the treatment of lymphocytic leukemia, acute myelogenous leukemia, germ cell tumours, Hodgkin's disease, rhabdomoysarcoma, ovarian cancer and newly diagnosed glioblastoma multiforma [12] [13] [14] [15] [16] . Although etoposide is an important anticancer drug, it has some side effects which include hair loss, nausea, anorexia, diarrhoea and low leucocyte and platelet counts. Etoposide is known to cause fetal damage and birth defects [17] [18] [19] . Etoposide phosphate is an improved formulation of etoposide with less toxicity and better solubility in water [20] . Teniposide is used for the treatment of lymphomas of acute refractory leukemia and that of brain and bladder tumors. It can be used in single drug therapy for induction of remission. However, teniposide is used less often than etoposide due to its hematological toxicity [21] . NK 611 is a novel podophyllotoxin derivative carrying a dimethylamino group at the D-glucose moiety. It has shown better antitumor activity than both etoposide and teniposide [22] . GL331 is another podophyllotoxin derivative developed by the glycoside substitution of etoposide for an aniline group. It has been found to be 40 times more potent than etoposide in their cytotoxicity assay [23] . TOP-53 and Tafluposide (F 11782) are other derivatives with better activities and are under clinical trials [24, 25] .
Podophyllotoxin and its derivatives are potent anticancer agents; their toxicities such as gastrointestinal toxicity limit their clinical use. Chemical modifications of the natural isolates and their derivatives are needed in order to achieve better therapeutic impact, i.e., lower sensitivity and higher efficacy. Podophyllotoxin derivatives like etoposide are associated with the problems of drug resistance and poor bioavailability. Therefore, effectiveness of these anticancer drugs is limited by development of drug resistance which is responsible for treatment failure in more than 90% of patients with metastatic disease. Therefore, efforts towards the development of new podophyllotoxin derivatives are very much required.
Pharmacological activity
Podophyllotoxin has been used as a medicine for more than 250 years. With plethora of pharmacological properties, Podophyllotoxin and its derivatives have been used in both the traditional and modern systems of medicine against a host of diseases.
Anticancer activity
The aryltetralin lactone podophyllotoxin and its derivatives etoposide, etopophos (etoposide phosphate), and teniposide have been successfully utilized in a variety of malignant conditions since the glucopyranoside derivative of podophyllotoxin was recognized as a potent anticancer drug [26, 27] . Podophyllotoxin has been found to be effective in the treatment of lung cancer, Wilms tumours, genital tumours and many other lymphomas and tumors. The podophyllotoxin derivative, etoposide is used in the treatment of breast, pancreatic, and small and large cell lung cancers, rhabdomoysarcoma, ovarian cancer and newly diagnosed glioblastoma multiforma [12, [14] [15] [16] . 
Antiviral activity
Podophyllotoxin and its derivatives have the ability to bind tubulin and disrupt the cellular cytoskeleton and thus interfere with viral replication. Besides this, synthetic podophyllotoxin analogs show inhibition of reverse transcriptase which may be exploited to develop anticancer drugs against a number of retroviruses such as the human immunodeciency virus (HIV) [27] . The aqueous extract of Podophyllum peltatum has showed strong antiviral activity [28] and podophyllotoxin was found to be the most active component in inhibiting the replication of measles and herpes simplex type I virus [29, 30] . Podophyllotoxin has also been used as an antiviral agent against human Papilloma virus (HPV) that causes condyloma acuminatum [31] Radioprotection Podophyllum hexandrum extract can arrest the cell division and therefore has the potential to act as radioprotectant.
Pre-irradiation administration of Podophyllum has been shown to ameliorate the acute radiation damage in the mouse jejunum [32] . Flavonoids present in various medicinal plants have been well documented for iron chelation properties [32, 33] . Radioprotective potential of Podophyllum in both in vivo and in vitro models against lethal doses of radiation has also been evaluated quite recently [6, [33] [34] [35] [36] . Podophylloquercetin present in Podophyllum extract is a flavanoid (Singh and Shah 1994) and may play a pivotal role in iron chelation and free radical scavenging [33] . A number of mechanisms like stabilization of membrane potential, time related regulation of apoptosis, free radical scavenging, modulation of cell cycle activities yielding protection to DNA and other sub cellular entities have been proposed to explain the radioprotective manifestation [6, 34] .
Antifungal activity
Synthetic drugs besides being expensive and inadequate are often with adulterations and side effects and therefore there has always been a need for the search of drugs from the natural sources. Podophyllum hexandrum has proved to be an important source for the treatment of a number of diseases. Antifungal properties of podophyllum hexandrum have already been reported. Recently the methanolic extract of Podophyllum hexandrum was tested for antifungal activity and it was found that that the extract showed strong antifungal activity Candida albicans and Aspergillus niger at four different concentrations. Lignans extracted from Podophyllum hexandrum have also shown strong antifungal activity against Epidermophyton floccosum, Curvularia lunata, Nigrospora oryzae, Microsporum canis, Allescheria boydii and Pleurotus ostreatus [37] .
Antioxidant activity
Different extracts of different parts of podophyllum like rhizome, petiole and leaves have been examined for antioxidant activity. The antioxidant activity of the ethyl acetate extract of the rhizome of P. hexandrum was investigated by using DPPH scavenging assay, hydroxyl assay, H 2 O 2 assay, superoxide assay, and reducing power under in vitro conditions and by determining the antioxidant enzyme activities and glutathione levels in the liver tissue homogenate of albino rats under in vivo conditions. All the methods have proven the effectiveness of the ethyl acetate extract compared to known antioxidants BHT and α-tocopherol [38] .
Ethyl acetate extract of rhizome led to the reduction in the CCl 4 -induced toxicity, particularly hepatotoxicity, by inhibiting lipid peroxidation, suppressing alanine aminotransferase (ALT), aspartate aminotransferase (AST) activities, and lactate dehydrogenase activity (LDH), and increasing antioxidant enzyme activity. Ethyl acetate and ethanol extracts of rhizome and petiole have also been examined for antioxidant activity and rhizome extracts have shown higher antioxidant activity than that of petiole [39] . Methanolic extract of Podophyllum hexandrum lowers the lipid peroxidation of H 2 O 2 treated rats in a dose dependent manner. Aqueous extract of Podophyllum hexandrum could protect the kidney and lung tissue against CCl 4 induced oxidative stress probably by increasing antioxidant defense activities [40] .
Other activities
Besides the above mentioned activities, many other activities of podophyllotoxin and its derevatives are also known. Podophyllotoxin preparations are on the market for dermatological use to treat genital warts [41] and recently, immune stimulatory activities of podophyllotoxin have also been reported [42, 43] . Penile warts in selected cases can be safely treated with 0.5-2% podophyllin self-applied by the patient at a fraction of the cost of commercially available podophyllotoxin. Podophyllotoxin has also proved effective in the treatment of rheumatoid arthritis [44] .
Mode of action
The mode of action of Podophyllotoxin as amitotic inhibitor has been fully elucidated. Podophyllotoxin binds at the clochicine site of tubulin, inhibiting microtubule assembly and arrests the cell cycle in metaphase [45] . Podophyllotoxin also appears to attach to cell proteins and act by increasing the incorporation of amino acids into proteins, inhibition of purine synthesis and inhibition of purine incorporation into RNA. Podophyllotoxin has been found to inhibit RNA synthesis by inhibiting purine synthesis and its incorporation into RNA. The bioactive lignan also leads to the reduction in the activity of cytochrome oxidase and succinoxidase and interferes with the normal functioning of mitochondria [46] . To explain the radioprotective manifestation of podophyllum, several mechanisms including free radical scavenging, stabilization of membrane potential, time related regulation of apoptosis, modulation of cell cycle activities yielding protection to DNA and other sub cellular entities have been proposed [6, 34, 35] . Unlike the parent molecule, the semisynthetic derivatives, teniposide and etoposide show a different mode of action. They act as the inhibitors of DNA topoisomerase II. Topoisomerase II relaxes both negative and positive supercoils in an ATP dependent reaction by making a double-stranded break in one DNA duplex and passing another duplex region through it. The semisynthetic derivatives of podophyllotoxin bind this complex and prevent the repair of double stranded break, arresting the cells in late S phase or early G2 phase of cell cycle [47, 20] .
The role of biotechnology in the production of podophyllotoxin
Podophyllotoxin is of great importance because of its biological activity as a mitotic inhibitor and its therapeutic value as a starting compound of semisynthetic chemotherapeutic drugs etoposide, teniposide, and etoposide phosphate. It is isolated from the roots and rhizomes of Podophyllum hexandrum but the scarce occurrence of the plant puts limitations on the production of podophyllotoxin. To enhance podophyllotoxin, biotechnological tools can prove very handy.
Tissue culture
Micropropagation or somatic embryogenesis may prove to be a good alternative for the large scale cultivation of the plant. In vitro multiplication of P. hexandrum via somatic embryogenesis has already been reported [48] . Cell suspension cultures and callus cultures can yield better results and several authors have reported that accumulatation of podophyllotoxin and/or related lignans in specific cell lines [49, 50] . Initiation of callus and cell cultures from roots of P. hexandrum accumulated tumorinhibitory, 4'-demethylpodophyllotoxin as well as podophyllotoxin [51] . Coniferyl alcohol is a key-precursor of the biosynthetic pathway of podophyllotoxin and cultures supplemented with coniferyl alcohol showed enhanced podophyllotoxin accumulation, with a maximum of 0.012% on day 10 of the growth cycle [52] . Elicitorinduced podophyllotoxin accumulation in P. hexandrum cell cultures elicited with 100 μM MeJA showed 7-10 fold change in the podophyllotoxin accumulation as compared to the contol [53] .Tissue culture offers an effective and potential alternative of metabolite production because the amount of secondary metabolites produced in tissue cultures can be higher than in parent plants and provide an alternative to avoid problems associated with field production.
Agrobacterium mediated genetic Transformation
Transgenic hairy roots produced by infection of plants with Agrobacterium rhizogenes, are valuable source of root derived phytochemicals [54] and have been considered as the best experimental system for production of secondary metabolites' [55] . Many medicinal plants have been transformed successfully by A. rhizogenes and the hairy root induction caused an enhancement in the production of secondary metabolites as has been seen in case of Datura candida, Atropa belladonna and Catharanthus tricophyllum [56] . Agrobacterium rhizogenes transformed cell cultures of Podophyllum hexandrum showed enhanced accumulation of podophyllotoxin [55] but sometimes the biosynthesis of a valuable metabolite by hairy roots is limited by the availability of its precursor. One solution to address this problem is to add the desired product to the culture medium, but this cannot be economically feasible if the precursor is difficult to synthesize or if it has to be obtained from other natural sources. In this case, the coculture system can prove to be a judicious alternative as has been reported for the production of podophyllotoxin by Podophyllum hexandrum cell suspensions, synthesis of which is limited by the availability of coniferin. When Podophyllum hexandrum cells are cultured together with Linum flavum hairy roots, which produce and secrete coniferin, the production of podophyllotoxin was increased by 240% in the dual shaker flask system [57] . Hairy root cultures are genetically more stable and superior in their metabolic performance over suspension cultures of the cell line but scaling up hairy roots to industrial levels poses a great challenge at the moment and efficiency of the scaling up systems still needs optimization before industrial exploitation becomes valuable.
Metabolic engineering
Metabolic engineering is generally defined as the redirection of one or more enzymatic reactions to production of new compounds in an organism, enhance the production of existing compounds, or mediate the degradation of compounds by either overexpressing or suppressing one or more genes of a biosynthetic pathway [58] . Quite recently accumulation of a large amount of pinoresinol has been achieved by pathway engineering in F. koreana. Overexpression of the F. intermedia PLR gene in wheat results in an increase of an endogenous dibenzylbutane-class lignan, Secoisolariciresinol diglucoside (SDG) [59] . The transgenic periwinkle (Catharanthus roseus) cell culture, expressing an alkaloid biosynthetic gene with re-engineered substrate specificity, acquired the capacity to produce various exogenous alkaloids when co-cultured with the substrates [60] . Overexpression of squalene synthase genes in Panax ginseng [61] and Eleutherococcus senticosus [62] led to the enhanced accumulation of phytosterols and triterpenes. Moreover, overexpressing squalene synthase in Bupleurum falcatum resulted in enhanced production of both phytosterol and saikosaponins and increased the expression of downstream genes including squalene epoxidase and cycloartenol synthase [63] . Overexpression of the HMGR gene of the MEV pathway promoted artemisinin production [64] and the engineering of soyabean and canola to produce higher levels of monounsaturated fatty acids is yet another example of metabolic engineering [65] . Metabolic engineering has profound implications in biotechnological applications and can prove highly beneficial for enhancing the production of podophyllotoxin and other important lignans. The discovery of some key podophyllotoxin biosynthesis genes will stimulate the improvement in the metabolic engineering of Podophyllum hexandrum. The ability to switch on entire pathways by ectopic expression of transcription factors suggests new possibilities for engineering secondary metabolite pathways. Transcriptional factors often regulate many important genes in a particular pathway [66] and overexpression of these key regulatory genes may prove promising in metabolic engineering [67, 68] . One of the early instances of using this approach to manipulate plant biochemistry was the engineering of Arabidopsis to express the maize transcription factors C1 and R, which regulate production of anthocayanins in maize aleurone layers and this lead to the massive accumulation of anthocayanins in arabidopsis [69] . Such experiments hold a lot of promise for the plants like Podophyllum hexandrum where the genes coding for rate limiting enzymes and other key regulatory genes can be overexpressed or suppressed to enhance the biosynthesis of podophyllotoxin and other important lignans.
Conclusion and future prospects
Podophyllum hexandrum is an important medicinal herb, its roots and rhizomes being rich sources of podophyllotoxin which has cytotoxic and antitumor properties. Podophyllotoxin acts as a precursor for synthesis of modified compounds with a spectrum of biological activities. Inspite of the important biological activities of these compounds, the biosynthetic pathway is not yet fully elucidated thus demanding effort in this area. Further, because of the wide medicinal properties of this plant, intense collection of rhizomes from nature for podophyllotoxin extraction is being made. Also there is no organized method for commercial cultivation of this plant which has led to sudden decrease in the natural population of this plant. To overcome this problem, efficient tissue culture protocols need to be developed which will enable rapid multiplication and sustainable use of medicinal plants for future generations. The hairy root culture system is a potential approach for the production of podophyllotoxin, because of some important characteristics such as rapid growth rate, easy culture, genetic manipulation and most importantly, an increased ability to synthesize useful metabolites that cannot be produced by unorganized cells. Although several attempts for hairy root induction have been carried out but they have not shown promising results. So, efforts are required to develop efficient methods for hairy root induction and optimize them for better results.
The recent advances in functional genomics and metabolite profiling offer unprecedented opportunities to use the biochemical capacity of the plant to enhance the production of podophyllotoxin and other lignans. Although metabolic engineering can prove efficient in the production of podophyllotoxin and other related lignans but rational engineering of metabolic pathways in the plant requires a thorough knowledge of the whole podophyllotoxin biosynthetic pathways and a detailed understanding of the regulatory mechanisms controlling the onset and the flux of the pathways. In this case, integration of multiple biotechnological approaches might help in gaining knowledge and acquiring maximum output towards genome prospecting of this plant.
Conflict of interest
The authors declare that there is no conflict of interest.
